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Her hemoglobin level had dropped
further to 8.4 g/dL. Sputum culture
yielded substantial growth of methi-
cillin-sensitive Staphylococcus aureus
and  Pseudomonas aeruginosa. RT-
PCR results of throat and nasal swabs
were positive twice for coronavirus,
but coronavirus cultures from these
areas were negative. One month after
onset, her coronavirus antibody titer
was 200. In view of possible relapse
of SARS, she was treated with oral
ribavirin (1,200 mg/day) and
lopinavir (133.3 mg/day)/ritonavir
(33.3 mg) combination (3 capsules
twice a day) in addition to intravenous
piperacillin/tazobactam combination.
The patient was afebrile, and symp-
toms improved 3 days after admis-
sion. Serial chest radiograph showed
gradual resolution of shadowing.
Subsequent RT-PCR and sputum cul-
ture were negative.
This case illustrates several impor-
tant issues regarding problems of
infection control, diagnosis, and man-
agement of SARS. As the definition
of SARS is nonspecific, patients with
upper respiratory infection or commu-
nity-acquired pneumonia could be
mislabeled as having SARS.
Accommodating confirmed SARS
patients and patients mislabeled as
having SARS in the same facility may
be disastrous. Unfortunately, isolating
every single case is impossible, par-
ticularly when a large number of
patients are admitted. Our patient may
have acquired the disease after admis-
sion since she was placed in the same
ward with other patients confirmed to
have SARS. For this reason, special
cohorting of SARS patients with
closely related signs and symptoms
should be strictly implemented at
admission. Since fever is the most
common feature of SARS, isolating
febrile cases with respiratory or gas-
trointestinal symptoms may be appro-
priate. Even patients with fever alone
should be quarantined since the other
symptoms of SARS may not be clini-
cally obvious. Secondly, the sensitivi-
ty of diagnosing a coronavirus infec-
tion on admission is only 32% to 50%
by nasopharyngeal RT-PCR test (3,4).
Many infected cases will be missed as
a result. Our patient may have had a
relapse of disease during her second
admission, although she had positive
RT-PCR and antibody surge only 1
month after onset. However, we could
not conclude whether the first RT-
PCR on admission was a false nega-
tive or whether the patient acquired
coronavirus infection in the hospital.
Our study showed that sensitivity for
diagnosing coronavirus infection
could be increased by performing RT-
PCR on samples from different parts
of the body (4). Unfortunately, these
samples were not taken from our
patient. Furthermore, the chest infec-
tion with organisms recovered from
her sputum could be the sole reason
for her second admission, especially
when her immune system was weak-
ened by the administration of a high-
dose steroid. The presence of genetic
material for coronavirus from her
nasal cavity and throat might not sug-
gest that the virus is active. The
absence of coronavirus growth in this
patient might indicate that the virus is
no longer viable, although the culture
technique itself might not be sensitive
enough to justify this claim.
Therefore, further refinement of the
diagnostic techniques for SARS is
essential, especially for diagnosis dur-
ing early onset. Thirdly, giving treat-
ment to a patient without a legitimate
diagnosis may be inappropriate, espe-
cially when the treatment carries sub-
stantial adverse effects, as illustrated
in our patient, and a universally
accepted therapy has not been avail-
able. Whether lopinavir/ritonavir
combination is the key to a cure
remains to be clarified, despite the
satisfactory response that we
observed, since the clinical and radio-
logic improvement in our patient
might be the natural course of the dis-
ease. 
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Remembering
Jonathan M. Mann
in a World Ajar
September 2003 marks the
anniversary of the deaths of Jonathan
M. Mann and his wife Mary Lou
Clements aboard Swiss Air flight 111,
which crashed off the shore of Peggy’s
Cove, Nova Scotia, 5 years ago.
Although Jonathan and I were both
members of the Council of State andTerritorial Epidemiologists in the early
1980s, when Jonathan served as state
epidemiologist for New Mexico, our
paths did not cross until years later in
1990. Jonathan had reluctantly
resigned as director, Global AIDS
Activities, World Health Organization,
to become full professor at Harvard
School of Public Health. I had taken a
year’s leave of absence from my posi-
tion in Maine to enroll in Harvard’s
Master of Public Health program.
In a talk at the Centers for Disease
Control and Prevention, Jonathan
once outlined many of his hopes and
fears for AIDS activities worldwide.
Moved by his pleas for global com-
mitment to the epidemic, I sought out
Jonathan at the opening reception for
new Harvard students. I shared his
dreams for public health activism. We
believed in inspiring others to careers
in applied public health, so we initiat-
ed a brown bag lunch series for stu-
dents and faculty to share experiences
about work in public health (1). The
common thread throughout these dis-
cussions was universal human rights
and respect for human dignity.
Jonathan went on to establish the
Francis Xavier Bagnoud Center for
Health and Human Rights at the
Harvard School of Public Health and
used his position to promote health as
the broad-based core of human val-
ues. His lectures on universal human
rights centered on the idea that health
transcends geographic, political, eco-
nomic, and cultural barriers. Jonathan
drew on his past experiences with the
HIV epidemic to argue that the devel-
oping world would never achieve eco-
nomic or political stability unless the
health of its people improved. He
maintained that, if not addressed, the
health problems of the developing
world would pose a global threat.
“Public health,” he wrote, “too often
studies health without intruding upon
larger, societal, inescapably laden
issues…. If the public health mission
is to assure the conditions in which
people can achieve the highest attain-
able state of physical, mental and
social well-being, and if these essen-
tial conditions predominantly are
societal, then public health must work
for societal transformation” (2). 
Jonathan argued that discrimina-
tion and other violations of human
rights were primary pathologic forces
working against the improvement of
public health and that if we ignored
the plight of those whose rights were
violated, we would be less than
human ourselves. Jonathan very much
admired Eleanor Roosevelt, chair,
Declaration of Human Rights
Drafting Committee, who on the 10th
anniversary of the declaration asked,
“Where, after all, do universal human
rights begin? In small places, close to
home—so close and so small that they
cannot be seen on any map of the
world. Such are the places where
every man, woman and child seeks
equal justice, equal opportunity and,
equal dignity. Without concerted citi-
zen action to uphold them close to
home, we shall look in vain for
progress in the larger world” (3).
On Jonathan’s desk at Harvard,
amidst family photographs, was a
framed joker taken from an ordinary
deck of cards. When I asked about its
significance, he responded that,
despite life’s challenges, it remains
important to smile. So smile we must
at the memory of Jonathan and his
many accomplishments. Each year,
the Council of State and Territorial
Epidemiologists remembers by hold-
ing a distinguished lecture named in
honor of Jonathan M. Mann. 
The public health practitioner must
respond to the needs of people and yet
be sensitive to world politics. In solv-
ing difficult issues, the practitioner
must understand the interconnection of
social values and scientific truths and
work collaboratively with the medical
community. Moved to the forefront by
recent acts of terrorism, public health
has achieved recognition as first
responder and as integral part of plan-
ning for and responding to catastroph-
ic health crises. We cannot promote
safety and security if we fail to recog-
nize, and advocate for, people around
the globe who do not have access to
basic health care, adequate living and
working conditions, or education to
enlighten their response to life’s chal-
lenges. The anniversary of Dr. Mann’s
untimely death serves as reminder to
the medical and public health commu-
nities of the ongoing need to promote
universal human rights and to focus
energies and resources on a global
approach to public health.
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Mild Severe Acute
Respiratory
Syndrome
To the Editor: Severe acute respi-
ratory syndrome (SARS) is a recently
recognized infectious disease caused
by a novel human coronavirus
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